mitotane and carboplatin

mitotane has been researched along with carboplatin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baudin, E; Berdelou, A; Caramella, C; Hescot, S; Leboulleux, S; Lombes, M; Paci, A1
Albany, C; Chovanec, M; Hahn, N; Taza, F1
Fan, XX; Li, ZH; Wang, L; Wang, XY; Weng, Y; Yan, L; Zhang, SL1

Other Studies

3 other study(ies) available for mitotane and carboplatin

ArticleYear
Early progression under mitotane and polychemotherapy does not mean failure in adrenocortical carcinoma patient.
    Annales d'endocrinologie, 2017, Volume: 78, Issue:1

    Topics: Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Mitotane; Survival Rate; Treatment Outcome

2017
Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma.
    Clinical genitourinary cancer, 2017, Volume: 15, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Carboplatin; Combined Modality Therapy; Discoidin Domain Receptor 2; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Mitotane; Mutation; Neoplasm Metastasis; Nephrectomy; Tomography Scanners, X-Ray Computed

2017
Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Carboplatin; Etoposide; Humans; Male; Mitotane

2023